Thomas Thum

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 446 publications

Generation of diseased and isogenic control human induced pluripotent stem cell lines MHHi043-A & MHHi043-B from a female Fabry disease patient carrying c.644A > G missense mutation.

Generation of diseased and isogenic control human induced pluripotent stem cell lines MHHi043-A & MHHi043-B from a female Fabry disease patient carrying c.644A > G missense mutation.

Journal: Stem cell research

Published: July 24, 2026

Loss of lncRNA H19 impairs neonatal cardiac regeneration.

Loss of lncRNA H19 impairs neonatal cardiac regeneration.

Journal: American journal of physiology. Cell physiology

Published: June 25, 2026

Generation of human induced pluripotent stem cell line MHHi040-A from a female Fabry disease patient carrying c.644A>G missense mutation.

Generation of human induced pluripotent stem cell line MHHi040-A from a female Fabry disease patient carrying c.644A>G missense mutation.

Journal: Stem cell research

Published: June 16, 2026

Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction.

Serotonin 5-HT7 receptor signaling modulates inflammatory responses and survival after myocardial infarction.

Journal: Journal of translational medicine

Published: April 15, 2026

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial.

The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial.

Journal: Nature medicine

Published: February 19, 2026

Integrated Multi-omics Analysis Uncovers Molecular Dysregulation in Glycosylceramide Synthase-Deficient Human Induced Pluripotent Stem Cells.

Integrated Multi-omics Analysis Uncovers Molecular Dysregulation in Glycosylceramide Synthase-Deficient Human Induced Pluripotent Stem Cells.

Journal: Molecular & cellular proteomics : MCP

Published: January 26, 2026

Extracellular BRICK1 drives heart repair after myocardial infarction in mice.

Extracellular BRICK1 drives heart repair after myocardial infarction in mice.

Journal: Science translational medicine

Published: January 07, 2026

RNA splicing and cardiovascular disease: a guide for cardiologists.

RNA splicing and cardiovascular disease: a guide for cardiologists.

Journal: European heart journal

Published: January 05, 2026

Nucleoside-Modified mRNA Encoding Alpha-Galactosidase A Ameliorates Fabry Disease Phenotypes in Human IPSC-Derived Cardiomyocytes.

Nucleoside-Modified mRNA Encoding Alpha-Galactosidase A Ameliorates Fabry Disease Phenotypes in Human IPSC-Derived Cardiomyocytes.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 12, 2025

Pharmacological inhibition of myosin reduces the cytotoxic effect of a Lys49 PLA2-like myotoxin on human and rat cardiac muscle.

Pharmacological inhibition of myosin reduces the cytotoxic effect of a Lys49 PLA2-like myotoxin on human and rat cardiac muscle.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 25, 2025

Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.

Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: November 21, 2025

Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE.

Mechanistic insights into heart failure progression and therapeutic target discovery through plasma microRNA profiling: Findings from HOMAGE.

Journal: European journal of internal medicine

Published: September 24, 2025

Showing 1-12 of 446

Last Updated: 09/26/2026